Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy

Results: from the SEARCH database

Jessica C. Lloyd, Lionel L. Bañez, William J. Aronson, Martha Kennedy Terris, Joseph C. Presti, Christopher L. Amling, Christopher J. Kane, Stephen J. Freedland

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: To clarify the relationship between estimated blood loss (EBL) and biochemical recurrence, assessed by prostate-specific antigen (PSA) level, as blood loss is a long-standing concern associated with radical prostatectomy (RP), and no studies to date have examined the association between blood loss and cancer control. Patients and Methods: In all, 1077 patients were identified in the Shared Equal-Access Regional Cancer Hospital database who underwent retropubic RP (between 1998 and 2008) and had EBL and follow-up data available. We examined the relationship between EBL and recurrence using multivariate Cox regression analyses. Results: Increased EBL was correlated with PSA recurrence in a multivariate-adjusted model (P = 0.01). When analysed by 500-mL EBL categories, those with an EBL of <1500 mL had a similar risk of recurrence. However, the risk of PSA recurrence tended to increase for an EBL of 1500-3499 mL, before decreasing again for patients with an EBL of ≥3500 mL. Men with an EBL of 2500-3499 mL had more than twice the risk of recurrence than men with an EBL of <1500 mL (P = 0.02). EBL was not associated with adverse tumour stage, grade or margin status. Conclusion:s: There was a significant correlation between EBL at the time of RP and biochemical recurrence. We hypothesized that this association might be due to transfusion-related immunosuppression, excessive blood obscuring the operative field, EBL being a marker of aggressive disease, or EBL being a marker of poor surgical technique. However, our data did not completely fit any one of these hypotheses, and thus the ultimate cause for the increased risk of recurrence remains unclear and requires further study.

Original languageEnglish (US)
Pages (from-to)347-351
Number of pages5
JournalBJU International
Volume105
Issue number3
DOIs
StatePublished - Feb 1 2010
Externally publishedYes

Fingerprint

Prostate-Specific Antigen
Prostatectomy
Databases
Recurrence
Cancer Care Facilities
Immunosuppression

Keywords

  • Blood loss
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy : Results: from the SEARCH database. / Lloyd, Jessica C.; Bañez, Lionel L.; Aronson, William J.; Terris, Martha Kennedy; Presti, Joseph C.; Amling, Christopher L.; Kane, Christopher J.; Freedland, Stephen J.

In: BJU International, Vol. 105, No. 3, 01.02.2010, p. 347-351.

Research output: Contribution to journalArticle

Lloyd, Jessica C. ; Bañez, Lionel L. ; Aronson, William J. ; Terris, Martha Kennedy ; Presti, Joseph C. ; Amling, Christopher L. ; Kane, Christopher J. ; Freedland, Stephen J. / Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy : Results: from the SEARCH database. In: BJU International. 2010 ; Vol. 105, No. 3. pp. 347-351.
@article{77be5a8e47c2439cacf9d5c667d07c6d,
title = "Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: Results: from the SEARCH database",
abstract = "Objective: To clarify the relationship between estimated blood loss (EBL) and biochemical recurrence, assessed by prostate-specific antigen (PSA) level, as blood loss is a long-standing concern associated with radical prostatectomy (RP), and no studies to date have examined the association between blood loss and cancer control. Patients and Methods: In all, 1077 patients were identified in the Shared Equal-Access Regional Cancer Hospital database who underwent retropubic RP (between 1998 and 2008) and had EBL and follow-up data available. We examined the relationship between EBL and recurrence using multivariate Cox regression analyses. Results: Increased EBL was correlated with PSA recurrence in a multivariate-adjusted model (P = 0.01). When analysed by 500-mL EBL categories, those with an EBL of <1500 mL had a similar risk of recurrence. However, the risk of PSA recurrence tended to increase for an EBL of 1500-3499 mL, before decreasing again for patients with an EBL of ≥3500 mL. Men with an EBL of 2500-3499 mL had more than twice the risk of recurrence than men with an EBL of <1500 mL (P = 0.02). EBL was not associated with adverse tumour stage, grade or margin status. Conclusion:s: There was a significant correlation between EBL at the time of RP and biochemical recurrence. We hypothesized that this association might be due to transfusion-related immunosuppression, excessive blood obscuring the operative field, EBL being a marker of aggressive disease, or EBL being a marker of poor surgical technique. However, our data did not completely fit any one of these hypotheses, and thus the ultimate cause for the increased risk of recurrence remains unclear and requires further study.",
keywords = "Blood loss, Prostate cancer, Radical prostatectomy",
author = "Lloyd, {Jessica C.} and Ba{\~n}ez, {Lionel L.} and Aronson, {William J.} and Terris, {Martha Kennedy} and Presti, {Joseph C.} and Amling, {Christopher L.} and Kane, {Christopher J.} and Freedland, {Stephen J.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1111/j.1464-410X.2009.08792.x",
language = "English (US)",
volume = "105",
pages = "347--351",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy

T2 - Results: from the SEARCH database

AU - Lloyd, Jessica C.

AU - Bañez, Lionel L.

AU - Aronson, William J.

AU - Terris, Martha Kennedy

AU - Presti, Joseph C.

AU - Amling, Christopher L.

AU - Kane, Christopher J.

AU - Freedland, Stephen J.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Objective: To clarify the relationship between estimated blood loss (EBL) and biochemical recurrence, assessed by prostate-specific antigen (PSA) level, as blood loss is a long-standing concern associated with radical prostatectomy (RP), and no studies to date have examined the association between blood loss and cancer control. Patients and Methods: In all, 1077 patients were identified in the Shared Equal-Access Regional Cancer Hospital database who underwent retropubic RP (between 1998 and 2008) and had EBL and follow-up data available. We examined the relationship between EBL and recurrence using multivariate Cox regression analyses. Results: Increased EBL was correlated with PSA recurrence in a multivariate-adjusted model (P = 0.01). When analysed by 500-mL EBL categories, those with an EBL of <1500 mL had a similar risk of recurrence. However, the risk of PSA recurrence tended to increase for an EBL of 1500-3499 mL, before decreasing again for patients with an EBL of ≥3500 mL. Men with an EBL of 2500-3499 mL had more than twice the risk of recurrence than men with an EBL of <1500 mL (P = 0.02). EBL was not associated with adverse tumour stage, grade or margin status. Conclusion:s: There was a significant correlation between EBL at the time of RP and biochemical recurrence. We hypothesized that this association might be due to transfusion-related immunosuppression, excessive blood obscuring the operative field, EBL being a marker of aggressive disease, or EBL being a marker of poor surgical technique. However, our data did not completely fit any one of these hypotheses, and thus the ultimate cause for the increased risk of recurrence remains unclear and requires further study.

AB - Objective: To clarify the relationship between estimated blood loss (EBL) and biochemical recurrence, assessed by prostate-specific antigen (PSA) level, as blood loss is a long-standing concern associated with radical prostatectomy (RP), and no studies to date have examined the association between blood loss and cancer control. Patients and Methods: In all, 1077 patients were identified in the Shared Equal-Access Regional Cancer Hospital database who underwent retropubic RP (between 1998 and 2008) and had EBL and follow-up data available. We examined the relationship between EBL and recurrence using multivariate Cox regression analyses. Results: Increased EBL was correlated with PSA recurrence in a multivariate-adjusted model (P = 0.01). When analysed by 500-mL EBL categories, those with an EBL of <1500 mL had a similar risk of recurrence. However, the risk of PSA recurrence tended to increase for an EBL of 1500-3499 mL, before decreasing again for patients with an EBL of ≥3500 mL. Men with an EBL of 2500-3499 mL had more than twice the risk of recurrence than men with an EBL of <1500 mL (P = 0.02). EBL was not associated with adverse tumour stage, grade or margin status. Conclusion:s: There was a significant correlation between EBL at the time of RP and biochemical recurrence. We hypothesized that this association might be due to transfusion-related immunosuppression, excessive blood obscuring the operative field, EBL being a marker of aggressive disease, or EBL being a marker of poor surgical technique. However, our data did not completely fit any one of these hypotheses, and thus the ultimate cause for the increased risk of recurrence remains unclear and requires further study.

KW - Blood loss

KW - Prostate cancer

KW - Radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=75149120247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149120247&partnerID=8YFLogxK

U2 - 10.1111/j.1464-410X.2009.08792.x

DO - 10.1111/j.1464-410X.2009.08792.x

M3 - Article

VL - 105

SP - 347

EP - 351

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 3

ER -